Eric Lyons

Eric Lyons serves as a procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific, diagnostic, and technical resources. He manages a diverse portfolio of contracts enabling laboratory diagnostics, biomedical research, and data-driven public health operations, with a focus on securing high-precision analytical equipment, specialized consulting services, and outpatient care infrastructure. His work directly supports CDC’s rapid response capabilities and national disease surveillance systems, ensuring timely access to mission-critical technologies and expert services that underpin infectious disease detection and laboratory capacity building. While specific contractor relationships are not publicly enumerated, Lyons engages with a broad spectrum of vendors including analytical instrument manufacturers, scientific consultants, and precision equipment service providers. His contracting patterns reflect a preference for established technical partners capable of meeting stringent federal compliance and performance standards, particularly in areas requiring validated methodologies and regulatory alignment with public health protocols. Vendor partnerships are typically formed through competitive sealed bidding and performance-based contract structures to ensure accountability and scientific integrity. Lyons demonstrates a strong commitment to socioeconomic contracting, with nearly 90% of acquisitions conducted under full and open competition, while actively reserving approximately 5.3% of awards for service-disabled veteran-owned small businesses and another 5.3% for total small business set-asides under FAR 19.5. This balanced approach ensures broad market participation without compromising mission-critical requirements. His primary procurement focus lies in NAICS 621498 (outpatient care centers), 541690 (scientific and technical consulting), and 334516 (analytical laboratory instrument manufacturing), reflecting deep expertise in procuring diagnostic tools, epidemiological support services, and maintenance of high-complexity lab equipment. He consistently prioritizes vendors with proven capabilities in biosafety, data interoperability, and clinical laboratory accreditation standards.